
Sign up to save your podcasts
Or
TTR amyloidosis is increasingly recognized as a cause of diastolic heart failure and as much more common than previously thought. There are proven and investigational therapies that can slow or possibly stop this disease.
In this interview, Rodney H. Falk, MD, FACC and Alison L. Bailey, MD FACC, with Jonathan R. Salik, MD, discuss Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice.
3.7
5353 ratings
TTR amyloidosis is increasingly recognized as a cause of diastolic heart failure and as much more common than previously thought. There are proven and investigational therapies that can slow or possibly stop this disease.
In this interview, Rodney H. Falk, MD, FACC and Alison L. Bailey, MD FACC, with Jonathan R. Salik, MD, discuss Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice.
132 Listeners
322 Listeners
160 Listeners
862 Listeners
496 Listeners
272 Listeners
3,321 Listeners
87 Listeners
135 Listeners
1,081 Listeners
39 Listeners
186 Listeners
321 Listeners
424 Listeners
35 Listeners